Anna Wiles

693 total citations
17 papers, 437 citations indexed

About

Anna Wiles is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Anna Wiles has authored 17 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Anna Wiles's work include Cancer Research and Treatments (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and Virus-based gene therapy research (3 papers). Anna Wiles is often cited by papers focused on Cancer Research and Treatments (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and Virus-based gene therapy research (3 papers). Anna Wiles collaborates with scholars based in New Zealand, Australia and United Kingdom. Anna Wiles's co-authors include Janice A. Royds, Antony W. Braithwaite, Clare L. Thompson, Martin M. Knight, C. Anthony Poole, Noelyn Hung, Tania L. Slatter, Yu-Jen Chen, Hongjun Shi and David A. Hall and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Anna Wiles

17 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Wiles New Zealand 13 266 130 83 76 60 17 437
Meropi Athanasiou United States 12 450 1.7× 120 0.9× 81 1.0× 80 1.1× 53 0.9× 15 639
Julie Ross Canada 10 373 1.4× 86 0.7× 39 0.5× 51 0.7× 28 0.5× 14 497
Elena Savelieva United States 8 317 1.2× 238 1.8× 83 1.0× 70 0.9× 88 1.5× 9 540
Kunitoshi Chiba United States 10 546 2.1× 119 0.9× 70 0.8× 79 1.0× 248 4.1× 11 740
Margaret Bell United Kingdom 11 435 1.6× 222 1.7× 80 1.0× 75 1.0× 21 0.3× 19 560
Hashmat Sikder United States 6 366 1.4× 135 1.0× 46 0.6× 125 1.6× 19 0.3× 6 515
Van de Ven Wj Belgium 6 250 0.9× 89 0.7× 59 0.7× 69 0.9× 27 0.5× 8 491
Kazunobu Isogaya Japan 12 427 1.6× 180 1.4× 28 0.3× 98 1.3× 25 0.4× 15 533
Emmanuel Tubacher France 8 465 1.7× 95 0.7× 131 1.6× 170 2.2× 39 0.7× 11 708
Ingegerd Elvers Sweden 11 578 2.2× 132 1.0× 115 1.4× 126 1.7× 26 0.4× 14 710

Countries citing papers authored by Anna Wiles

Since Specialization
Citations

This map shows the geographic impact of Anna Wiles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wiles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wiles more than expected).

Fields of papers citing papers by Anna Wiles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Wiles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wiles. The network helps show where Anna Wiles may publish in the future.

Co-authorship network of co-authors of Anna Wiles

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wiles. A scholar is included among the top collaborators of Anna Wiles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wiles. Anna Wiles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wiles, Anna, Sunali Mehta, Adele G. Woolley, et al.. (2023). Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis. Arthritis Research & Therapy. 25(1). 62–62. 1 indexed citations
2.
Mehta, Sunali, Grégory Gimenez, Hamish G. Campbell, et al.. (2019). The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer. Cell Death and Disease. 10(9). 631–631. 32 indexed citations
3.
Mehta, Sunali, et al.. (2018). A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation. Mammalian Genome. 29(11-12). 831–842. 14 indexed citations
4.
Campbell, Heather, Claire Vennin, Michelle Wilson, et al.. (2016). The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene. 35(38). 4981–4989. 30 indexed citations
5.
Hung, Noelyn, Kirsten A. Ward‐Hartstonge, Anna Wiles, et al.. (2016). Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma. Modern Pathology. 29(3). 212–226. 19 indexed citations
6.
Thompson, Clare L., et al.. (2015). Lithium chloride prevents interleukin‐1β induced cartilage degradation and loss of mechanical properties. Journal of Orthopaedic Research®. 33(10). 1552–1559. 21 indexed citations
7.
Vermunt, Jane, et al.. (2015). Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand. World Journal of Gastroenterology. 21(35). 10224–10233. 10 indexed citations
8.
Thompson, Clare L., Anna Wiles, C. Anthony Poole, & Martin M. Knight. (2015). Lithium chloride modulates chondrocyte primary cilia and inhibits Hedgehog signaling. The FASEB Journal. 30(2). 716–726. 56 indexed citations
9.
Hung, Noelyn, Yu-Jen Chen, Magnus Olivecrona, et al.. (2014). Increased paired box transcription factor 8 has a survival function in Glioma. BMC Cancer. 14(1). 159–159. 12 indexed citations
10.
Stayner, Cherie, et al.. (2012). Primary cilia defects in the polycystic kidneys from an ovine model of Meckel Gruber syndrome. Europe PMC (PubMed Central). 1(S1). 1 indexed citations
11.
Royds, Janice A., Anna Wiles, Yu-Jen Chen, et al.. (2011). The CDKN2A G500 Allele Is More Frequent in GBM Patients with No Defined Telomere Maintenance Mechanism Tumors and Is Associated with Poorer Survival. PLoS ONE. 6(10). e26737–e26737. 29 indexed citations
12.
Woolley, Adele G., Anna Wiles, Noelyn Hung, et al.. (2011). Prognostic Association of YB-1 Expression in Breast Cancers: A Matter of Antibody. PLoS ONE. 6(6). e20603–e20603. 29 indexed citations
13.
Slatter, Tania L., Anna Wiles, Yu-Jen Chen, et al.. (2010). Pilocytic Astrocytomas Have Telomere-Associated Promyelocytic Leukemia Bodies without Alternatively Lengthened Telomeres. American Journal Of Pathology. 177(6). 2694–2700. 21 indexed citations
14.
Hibma, Merilyn, Anna Wiles, Brett R. Dix, et al.. (2009). Increased apoptosis and reduced replication efficiency of the E3 region-modified dl309 adenovirus in cancer cells. Virus Research. 145(1). 112–120. 6 indexed citations
15.
Chen, Yu-Jen, Hamish G. Campbell, Anna Wiles, et al.. (2008). PAX8 Regulates Telomerase Reverse Transcriptase and Telomerase RNA Component in Glioma. Cancer Research. 68(14). 5724–5732. 36 indexed citations
16.
Macartney‐Coxson, Donia, Kylie Hood, Hongjun Shi, et al.. (2008). Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer. 8(1). 187–187. 80 indexed citations
17.
Royds, Janice A., Merilyn Hibma, Brett R. Dix, et al.. (2005). p53 promotes adenoviral replication and increases late viral gene expression. Oncogene. 25(10). 1509–1520. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026